Leptofuranin A
Latest Information Update: 30 Jun 1998
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Class Cytostatic antibiotics; Furans; Pyrones
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 30 Jun 1998 No-Development-Reported for Cancer in Japan (Unknown route)
- 23 Oct 1996 Preclinical development for Cancer in Japan (Unknown route)